Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Total Debt (2016 - 2026)

Insmed's Total Debt history spans 15 years, with the latest figure at $542.2 million for Q1 2026.

  • Quarterly Total Debt fell 50.93% to $542.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $542.2 million through Mar 2026, down 50.93% year-over-year, with the annual reading at $541.0 million for FY2025, 50.97% down from the prior year.
  • Total Debt came in at $542.2 million for Q1 2026, roughly flat from $541.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.2 billion in Q2 2024 to a low of $538.5 million in Q2 2025.
  • The 5-year median for Total Debt is $1.1 billion (2024), against an average of $924.2 million.
  • Year-over-year, Total Debt soared 116.6% in 2022 and then plummeted 54.02% in 2025.
  • Insmed's Total Debt stood at $1.1 billion in 2022, then increased by 2.67% to $1.2 billion in 2023, then fell by 4.49% to $1.1 billion in 2024, then crashed by 50.97% to $541.0 million in 2025, then increased by 0.23% to $542.2 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Total Debt are $542.2 million (Q1 2026), $541.0 million (Q4 2025), and $539.7 million (Q3 2025).